Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase subunit c is an essential part of the F₀ sector of ATP synthase in mycobacteria, forming a multi-copy ring (c-ring) within the cytoplasmic membrane that drives ATP production via rotary catalysis powered by the proton-motive force[1][2]. In Mycobacterium tuberculosis, the c subunit (commonly termed AtpE) forms the drug-binding site for bedaquiline, a first-in-class antitubercular agent. The subunit is directly involved in translocating protons across the membrane, which rotates the c-ring and drives conformational changes in the F₁ sector, thereby synthesizing ATP. As an essential membrane protein facilitating ATP generation, it is indispensable for mycobacterial survival, especially under hypoxic or persistent infection conditions[2][7]. Targeting subunit c has led to the development of highly potent antimycobacterial drugs, although resistance can emerge through mutation of the atpE gene[6].
Inhibition of proton translocation by binding to subunit c, thereby blocking ATP synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase subunit c (mycobacteria) (AtpE).